206 related articles for article (PubMed ID: 20068553)
1. A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.
Sterman DH; Recio A; Haas AR; Vachani A; Katz SI; Gillespie CT; Cheng G; Sun J; Moon E; Pereira L; Wang X; Heitjan DF; Litzky L; June CH; Vonderheide RH; Carroll RG; Albelda SM
Mol Ther; 2010 Apr; 18(4):852-60. PubMed ID: 20068553
[TBL] [Abstract][Full Text] [Related]
2. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
[TBL] [Abstract][Full Text] [Related]
3. A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.
Sterman DH; Haas A; Moon E; Recio A; Schwed D; Vachani A; Katz SI; Gillespie CT; Cheng G; Sun J; Papasavvas E; Montaner LJ; Heitjan DF; Litzky L; Friedberg J; Culligan M; June CH; Carroll RG; Albelda SM
Am J Respir Crit Care Med; 2011 Dec; 184(12):1395-9. PubMed ID: 21642245
[TBL] [Abstract][Full Text] [Related]
4. Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy.
Sterman DH; Alley E; Stevenson JP; Friedberg J; Metzger S; Recio A; Moon EK; Haas AR; Vachani A; Katz SI; Sun J; Heitjan DF; Hwang WT; Litzky L; Yearley JH; Tan KS; Papasavvas E; Kennedy P; Montaner LJ; Cengel KA; Simone CB; Culligan M; Langer CJ; Albelda SM
Clin Cancer Res; 2016 Aug; 22(15):3791-800. PubMed ID: 26968202
[TBL] [Abstract][Full Text] [Related]
5. Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.
Keshava S; Rao LV; Pendurthi UR
Sci Rep; 2016 Nov; 6():36829. PubMed ID: 27833109
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
Sterman DH; Treat J; Litzky LA; Amin KM; Coonrod L; Molnar-Kimber K; Recio A; Knox L; Wilson JM; Albelda SM; Kaiser LR
Hum Gene Ther; 1998 May; 9(7):1083-92. PubMed ID: 9607419
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
8. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.
Zarogoulidis P; Chatzaki E; Hohenforst-Schmidt W; Goldberg EP; Galaktidou G; Kontakiotis T; Karamanos N; Zarogoulidis K
Cancer Gene Ther; 2012 Sep; 19(9):593-600. PubMed ID: 22744209
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy.
Odaka M; Wiewrodt R; DeLong P; Tanaka T; Zhang Y; Kaiser L; Albelda S
Mol Ther; 2002 Aug; 6(2):210-8. PubMed ID: 12161187
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
Sterman DH; Recio A; Vachani A; Sun J; Cheung L; DeLong P; Amin KM; Litzky LA; Wilson JM; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Oct; 11(20):7444-53. PubMed ID: 16243818
[TBL] [Abstract][Full Text] [Related]
11. Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.
Aggarwal C; Haas AR; Metzger S; Aguilar LK; Aguilar-Cordova E; Manzanera AG; Gómez-Hernández G; Katz SI; Alley EW; Evans TL; Bauml JM; Cohen RB; Langer CJ; Albelda SM; Sterman DH
Mol Ther; 2018 May; 26(5):1198-1205. PubMed ID: 29550074
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma.
Sterman DH; Molnar-Kimber K; Iyengar T; Chang M; Lanuti M; Amin KM; Pierce BK; Kang E; Treat J; Recio A; Litzky L; Wilson JM; Kaiser LR; Albelda SM
Cancer Gene Ther; 2000 Dec; 7(12):1511-8. PubMed ID: 11228529
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural immunotherapy: An update on emerging treatment strategies for pleural malignancy.
Murthy V; Katzman D; Sterman DH
Clin Respir J; 2019 May; 13(5):272-279. PubMed ID: 30810270
[TBL] [Abstract][Full Text] [Related]
14. Interferon beta adenoviral gene therapy in a patient with ovarian cancer.
Sterman DH; Gillespie CT; Carroll RG; Coughlin CM; Lord EM; Sun J; Haas A; Recio A; Kaiser LR; Coukos G; June CH; Albelda SM; Vonderheide RH
Nat Clin Pract Oncol; 2006 Nov; 3(11):633-9. PubMed ID: 17080181
[TBL] [Abstract][Full Text] [Related]
15. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM
Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral gene transfer is inhibited by soluble factors in malignant pleural effusions.
Batra RK; Dubinett SM; Henkle BW; Sharma S; Gardner BK
Am J Respir Cell Mol Biol; 2000 May; 22(5):613-9. PubMed ID: 10783134
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment.
Grigoriu BD; Chahine B; Vachani A; Gey T; Conti M; Sterman DH; Marchandise G; Porte H; Albelda SM; Scherpereel A
Am J Respir Crit Care Med; 2009 May; 179(10):950-4. PubMed ID: 19201924
[TBL] [Abstract][Full Text] [Related]
18. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
Kang MQ; Cao YP; Deng F
Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
[TBL] [Abstract][Full Text] [Related]
19. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
20. Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.
Chintala NK; Choe JK; McGee E; Bellis R; Saini JK; Banerjee S; Moreira AL; Zauderer MG; Adusumilli PS; Rusch VW
Front Immunol; 2023; 14():1112960. PubMed ID: 36875061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
